These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 1211398)

  • 21. Pharmaceutical services in U.S. hospitals in 1989.
    Raehl CL; Bond CA; Pitterle ME
    Am J Hosp Pharm; 1992 Feb; 49(2):323-46. PubMed ID: 1553999
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comparison of premixed and non-premixed potassium chloride large-volume parenterals.
    Turco SJ
    Hosp Pharm; 1979 Dec; 14(12):720-2. PubMed ID: 10309085
    [No Abstract]   [Full Text] [Related]  

  • 23. Recommended standards of practice, policies, and procedures for intravenous therapy. National Coordinating Committee on Large Volume Parenterals.
    Am J Hosp Pharm; 1980 May; 37(5):660-3. PubMed ID: 7386473
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacists' opinions about and compliance with recommendations for intravenous admixture practices.
    Brzozowski DF; Hale KM; Segal R; Mirtallo JM
    Am J Hosp Pharm; 1987 Sep; 44(9):2077-84. PubMed ID: 3479020
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cost and time required to add potassium chloride to large-volume parenterals.
    Turco SJ
    Hosp Pharm; 1979 Dec; 14(12):718-9. PubMed ID: 10309084
    [No Abstract]   [Full Text] [Related]  

  • 26. [Study of insoluble contaminants in large-volume parental infusion fluids, II. Evaluation of the degree of contamination with insoluble particles of parenteral infusion fluids produced by the pharmaceutical industry and hospital pharmacies].
    Pawlaczyk J; Nowacka D; Wawrzyńczak D
    Acta Pol Pharm; 1982; 39(1-3):151-7. PubMed ID: 7180545
    [No Abstract]   [Full Text] [Related]  

  • 27. Work analysis of an admixture service.
    Sebastian G; Thielke TS
    Am J Hosp Pharm; 1983 Dec; 40(12):2149-53. PubMed ID: 6419588
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quality control in admixture services.
    Zellmer WA
    Am J Hosp Pharm; 1978 May; 35(5):527-8. PubMed ID: 655175
    [No Abstract]   [Full Text] [Related]  

  • 29. Reporting drug product defects--JCAHO.
    Hoffmann RP
    Hosp Pharm; 1989 Feb; 24(2):143-4. PubMed ID: 10318199
    [No Abstract]   [Full Text] [Related]  

  • 30. Pharmacy.
    Jeffrey LP
    Hospitals; 1972 Apr; 46(7):155-60. PubMed ID: 4552323
    [No Abstract]   [Full Text] [Related]  

  • 31. Improving adverse drug reaction reporting in the community setting.
    McCloskey BA
    Med Interface; 1996 May; 9(5):85-7. PubMed ID: 10157690
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Annual administrative reviews: pharmacy.
    Black HJ
    Hospitals; 1973 Apr; 47(7):153-5 passim. PubMed ID: 4573778
    [No Abstract]   [Full Text] [Related]  

  • 33. Clinical pharmacy services, pharmacy staffing, and adverse drug reactions in United States hospitals.
    Bond CA; Raehl CL
    Pharmacotherapy; 2006 Jun; 26(6):735-47. PubMed ID: 16716127
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adventitious contamination of intravenous admixtures during sterility testing.
    Bernick JJ; Brown DG; Bell JE
    Am J Hosp Pharm; 1979 Nov; 36(11):1493-6. PubMed ID: 517534
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A survey of adverse drug reaction reporting programs in select hospitals.
    Case RL; Guzzetti PJ
    Hosp Pharm; 1986 May; 21(5):423-6, 431-4, 438. PubMed ID: 10276799
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Particulate matter in small volume parenterals: evaluation of some technological and analytical aspects.
    Cirannni Signoretti E; Montanari I; Neri G; De Sena C; Alimonti S
    Boll Chim Farm; 1989 Feb; 128(2):65-70. PubMed ID: 2775519
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adverse drug event surveillance and drug withdrawals in the United States, 1969-2002: the importance of reporting suspected reactions.
    Wysowski DK; Swartz L
    Arch Intern Med; 2005 Jun; 165(12):1363-9. PubMed ID: 15983284
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Methods of reporting hospital financial information.
    Speranzo AJ
    Am J Hosp Pharm; 1984 Jul; 41(7):1367-72. PubMed ID: 6380277
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacy-based distribution system for enteral nutrition products.
    Craig SA; Paulson MF
    Am J Hosp Pharm; 1985 Dec; 42(12):2691-4. PubMed ID: 3936356
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An update on ready-to-use intravenous delivery systems.
    Maliekal J; Bertch KE; Witte KW
    Hosp Pharm; 1993 Oct; 28(10):970-1, 975-7. PubMed ID: 10171701
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.